THAR
Price:
$2.47
Market Cap:
$86.56M
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed...[Read more]
Industry
Biotechnology
IPO Date
2022-01-12
Stock Exchange
NASDAQ
Ticker
THAR
According to Tharimmune, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.17. This represents a change of -18.38% compared to the average of 1.43 of the last 4 quarters.
The mean historical Current Ratio of Tharimmune, Inc. over the last ten years is 2.28. The current 1.17 Current Ratio has changed 5.03% with respect to the historical average. Over the past ten years (40 quarters), THAR's Current Ratio was at its highest in in the June 2022 quarter at 13.13. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
2.28
Median
0.84
Minimum
0.04
Maximum
6.03
Discovering the peaks and valleys of Tharimmune, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.16%
Maximum Annual Current Ratio = 6.03
Minimum Annual Increase = -74.44%
Minimum Annual Current Ratio = 0.04
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.54 | -74.44% |
| 2023 | 6.03 | 3.24% |
| 2022 | 5.84 | 4.16% |
| 2021 | 0.14 | 26.77% |
| 2020 | 0.11 | 199.07% |
The current Current Ratio of Tharimmune, Inc. (THAR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.47
5-year avg
2.73
10-year avg
2.28
Tharimmune, Inc.’s Current Ratio is less than BioLineRx Ltd. (2.06), less than GeoVax Labs, Inc. (3.57), less than Adlai Nortye Ltd. (1.41), greater than Lunai Bioworks Inc. (0.04), less than SeaStar Medical Holding Corporation (3.66), less than Adaptimmune Therapeutics plc (1.52), less than Ainos, Inc. (2.96), less than Apollomics, Inc. (1.39), greater than Aditxt, Inc. (0.02), less than Moleculin Biotech, Inc. (1.39),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.06 | $14.17M | |
| 3.57 | $9.73M | |
| 1.41 | $37.48M | |
| 0.04 | $23.14M | |
| 3.66 | $10.01M | |
| 1.52 | $75.16M | |
| 2.96 | $12.03M | |
| 1.39 | $16.27M | |
| 0.02 | $62.61K | |
| 1.39 | $9.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tharimmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tharimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tharimmune, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tharimmune, Inc. (THAR)?
What is the highest Current Ratio for Tharimmune, Inc. (THAR)?
What is the 3-year average Current Ratio for Tharimmune, Inc. (THAR)?
What is the 5-year average Current Ratio for Tharimmune, Inc. (THAR)?
How does the current Current Ratio for Tharimmune, Inc. (THAR) compare to its historical average?